ProKidney to acquire manufacturing facility in North Carolina for REACT commercial production
ProKidney, a late clinical-stage cellular therapeutics company, has announced plans to acquire a 210,000 square foot facility and approximately 22 acres of land in Greensboro, North Carolina. The move is aimed at meeting the company’s future commercial manufacturing needs for REACT, a renal autologous cell therapy currently in Phase 3 development for treating diabetic chronic […]